Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/22/2025

Management of Nausea and Vomiting in Pregnancy

First-Line Treatment

  • The European Association for the Study of the Liver endorses doxylamine-pyridoxine as first-line treatment for nausea and vomiting in pregnancy. 1

  • ACOG recommends doxylamine-pyridoxine as first-line therapy for nausea and vomiting in pregnancy. 2

Dosing Strategy

  • Doxylamine-pyridoxine should be started with 2 tablets daily (one at bedtime), with each tablet containing doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg. 2

  • Doxylamine-pyridoxine can be titrated up to 4 tablets daily based on symptom response. 2

Second-Line Treatment

  • Promethazine functions as an H1-receptor antagonist with established safety throughout pregnancy. 2

  • Promethazine is an alternative antiemetic with extensive clinical experience but more sedating side effects compared to first-line therapy. 1

  • Promethazine can be administered intravenously in severe cases requiring hospitalization. 2

Comparative Efficacy

  • In hospitalized hyperemesis gravidarum patients, promethazine and metoclopramide show similar efficacy, but metoclopramide causes less drowsiness, dizziness, dystonia, and fewer treatment discontinuations. 1

  • A Cochrane meta-analysis found no significant efficacy differences among metoclopramide, ondansetron, and promethazine. 1

  • Metoclopramide is the preferred third-line agent over promethazine for refractory cases. 2

Safety Considerations by Gestational Age

  • Particular caution should be exercised with all antiemetics before 10 weeks gestation. 2

  • Ondansetron carries small absolute risk increases for cleft palate (0.03%) and ventricular septal defects (0.3%) when used early in pregnancy. 2

  • Methylprednisolone increases cleft palate risk before 10 weeks gestation and should be reserved as last resort. 1, 2

Adverse Effects Management

  • Both phenothiazines (including promethazine) and metoclopramide can cause extrapyramidal adverse effects. 1

  • The medication should be withdrawn immediately if extrapyramidal symptoms develop. 1, 2

Thiamine Supplementation

  • Thiamine supplementation (100 mg daily for minimum 7 days, then 50 mg daily maintenance) should be provided in cases of prolonged vomiting to prevent Wernicke encephalopathy. 1, 2

  • Thiamine should be started before any dextrose administration. 2

Indications for Hospitalization

  • Hospitalization is indicated for persistent vomiting despite oral antiemetics. 2

  • Signs of dehydration (orthostatic hypotension, decreased skin turgor, dry mucous membranes) warrant hospitalization. 1, 2

  • Weight loss greater than 5% of prepregnancy weight is an indication for hospitalization. 2

  • Inability to tolerate oral intake requires hospitalization. 2

  • Electrolyte abnormalities on laboratory evaluation are an indication for hospitalization. 1, 2

Clinical Monitoring

  • In severe cases, liver enzymes should be monitored, as 40-50% of hyperemesis gravidarum patients develop elevated transaminases. 1, 2

Treatment Approach

  • Early antiemetic intervention prevents progression to hyperemesis gravidarum, with the window for preventing severe disease typically between 4-12 weeks gestation. 2

  • Promethazine should not be used as first-line therapy when doxylamine-pyridoxine is available, as the latter has superior safety documentation and FDA approval specifically for this indication. 1, 2

Morning Sickness Management

Initial Non-Pharmacologic Management

  • The American Gastroenterological Association recommends starting with dietary and lifestyle modifications, including eating small, frequent, bland meals following the BRAT diet with high-protein and low-fat content, to manage morning sickness symptoms 3
  • Reducing spicy, fatty, acidic, and fried foods can help alleviate morning sickness symptoms, as suggested by the American Gastroenterological Association 4
  • Identifying and avoiding specific triggers, such as foods with strong odors or particular activities, is recommended by the American Gastroenterological Association to manage morning sickness symptoms 3

First-Line OTC Pharmacologic Treatment

  • The American College of Obstetricians and Gynecologists (ACOG) recommends ginger or vitamin B6 as first-line options for morning sickness treatment, with a dosing of 250 mg capsule taken 4 times daily for ginger 3
  • Vitamin B6 (pyridoxine) is recommended by ACOG at a dosing of 10-25 mg every 8 hours to reduce morning sickness symptoms 3, 4

Second-Line OTC Treatment: Doxylamine-Pyridoxine Combination

  • The FDA approves the combination of doxylamine and pyridoxine for nausea and vomiting in pregnancy, and ACOG recommends it for persistent symptoms refractory to non-pharmacologic therapy 3
  • The combination of doxylamine and pyridoxine is available in 10 mg/10 mg and 20 mg/20 mg combinations and is safe and well tolerated throughout pregnancy, as stated by the FDA and ACOG 3

H1-Receptor Antagonists (Prescription Required)

  • The American Gastroenterological Association considers H1-receptor antagonists like doxylamine (in higher doses), promethazine, and dimenhydrinate as safe first-line pharmacologic antiemetic therapies, requiring prescription for higher doses beyond OTC formulations 3

Critical Timing Consideration

  • Early intervention with antiemetics may prevent progression to hyperemesis gravidarum, which affects 0.3%-2% of pregnant women and can lead to serious complications, as stated by the American Gastroenterological Association 3
  • Hyperemesis gravidarum can cause dehydration, weight loss >5% of prepregnancy weight, and electrolyte imbalances, according to the American Gastroenterological Association 3

When to Seek Medical Attention

  • The American Gastroenterological Association advises patients to seek medical care if they experience signs of dehydration, such as orthostatic hypotension, decreased skin turgor, and dry mucous membranes 3